Inactive Instrument

Analyst Reco. Halyard Health Inc Nyse

Equities

US40650V1008

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

KeyBanc Downgrades Avanos Medical to Sector Weight From Overweight on 'Uncertain' Near-Term Outlook, Lack of Upside Catalysts	25/07/23	MT
CL King Initiates Avanos Medical at Buy Rating With $31 Price Target	22/05/23	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $26 From $28, Keeps Underweight Rating	04/05/23	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $28 From $26, Maintains Underweight Rating	22/02/23	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $26 From $24, Maintains Underweight Rating	06/01/23	MT
KeyBanc Adjusts Avanos Medical' Price Target to $34 From $38, Keeps Overweight Rating	03/11/22	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $24 From $28, Reiterates Underweight Rating	11/10/22	MT
KeyBanc Adjusts Avanos Medical's Price Target to $38 from $41, Keeps Overweight Rating	10/08/22	MT
Stifel Nicolaus Adjusts Avanos Medical's Price Target to $28 From $37, Maintains Hold Rating	18/07/22	MT
Morgan Stanley Adjusts Price Target on Avanos Medical to $28 From $33, Maintains Underweight Rating	15/07/22	MT
Morgan Stanley Adjusts Avanos Medical's Price Target to $33 from $36, Keeps Underweight Rating	05/05/22	MT
KeyBanc Adjusts Avanos Medical's Price Target to $41 From $47, Maintains Overweight Rating	24/02/22	MT
Berenberg Bank Terminates Coverage on a Number of Companies Due to Analysts' Departures From the Firm	13/12/21	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Price Target on Avanos Medical to $41 From $45, Maintains Underweight Rating	04/08/21	MT
AVANOS MEDICAL : Berenberg Bank Adjusts Avanos Medical PT to $45 From $50, Maintains Buy Rating	04/08/21	MT
AVANOS MEDICAL : Stephens Cuts Avanos Medical to Equal-Weight From Overweight, Price Target to $45 From $60	04/08/21	MT
AVANOS MEDICAL : KeyBanc Adjusts Avanos Medical's Price Target to $47 From $55, Keeps Overweight Rating	04/08/21	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Avanos Medical's Price Target to $45 from $36, Keeps Underweight Rating	15/12/20	MT
AVANOS MEDICAL : KeyBanc Adjusts Avanos Medical's Price Target to $47 From $43, Keeps at Overweight	04/11/20	MT
AVANOS MEDICAL : Morgan Stanley Adjusts Avanos Medical's Price Target to $36 From $31, Keeps Underweight Rating	04/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Halyard Health Inc Nyse

Equities

US40650V1008

Analyst Reco.

Filters